Globally, enteropathogenic bacteria are a major cause of morbidity and mortality. 1-3
Campylobacter, Salmonella, Shiga-toxin-producing Escherichia coli, and Listeria are among …

Clostridioides difficile is a Gram-positive, spore-forming, anaerobic bacterium. The clinical
features of C. difficile infections (CDIs) can vary, ranging from the asymptomatic carriage and …

Clostridioides difficile is responsible for post-antibiotic diarrhea and most of the
pseudomembranous colitis cases. Multiple recurrences, one of the major challenges faced …

Objectives Clostridioides difficile infection (CDI) is a common healthcare-associated
infection and leading cause of gastroenteritis-related mortality worldwide. However, data on …

The microbiota inhabiting the intestinal tract provide several critical functions to its host.
Microorganisms found at the mucosal layer form organized three-dimensional structures …

Clostridioides difficile (C. difficile) is responsible for a high percentage of gastrointestinal
infections and its pathological activity is due to toxins A and BC difficile infection (CDI) is …

The burden of emerging antimicrobial resistance (AMR) in the United States is significant
and even greater worldwide. Mitigation efforts have decreased the incidence and deaths …

Recurrent Clostridioides difficile infection (RCDI) causes an increased burden on the
healthcare system. We calculated RCDI incidence and identified factors associated with …

Viral infections as well as changes in the composition of the intestinal microbiota and virome
have been linked to cancer. Moreover, the success of cancer immunotherapy with …

Antibiotic exposure is a crucial risk factor for community-acquired Clostridioides difficile
infection (CA-CDI). However, the relative risks associated with specific antibiotics may vary …